BackNatus Medical Overview

Natus Medical Profit Margin

Latest profit margin for Natus Medical: 2.65% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

1.59%
23.80% YoY

As of Mar 2022

Annual Profit Margin (TTM)

2.65%
205.18% YoY

Trailing 12 months ending Mar 2022

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Natus Medical (NTUS) FAQ

Natus Medical (NTUS) currently reports a profit margin of 2.65% as of March 2022. That compares with -2.52% in the prior-year period — up 205.2% year over year. That is below the Healthcare sector average of 15.58%. Use the charts on this page to explore Natus Medical's profit margin history and peer comparisons.

Natus Medical's profit margin increased from -2.52% to 2.65% — a 205.2% year-over-year increase (period ending March 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Natus Medical's profit margin of 2.65% is lower than the Healthcare sector average of 15.58%. That is roughly 83.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Natus Medical's current 2.65% should be judged against Healthcare norms (sector average: 15.58%) and against NTUS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 2.65%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.58%. From there, open related valuation or income-statement pages for Natus Medical, and consider following NTUS for alerts when major investors trade the stock.